Literature DB >> 27122586

Robust Lys63-Linked Ubiquitination of RIG-I Promotes Cytokine Eruption in Early Influenza B Virus Infection.

Jingwen Jiang1,2, Jing Li3, Wenhui Fan2, Weinan Zheng2, Meng Yu2, Can Chen2, Lei Sun2, Yuhai Bi2, Chan Ding4, George F Gao1,2,5, Wenjun Liu6,2,5.   

Abstract

UNLABELLED: Influenza A and B virus infections both cause a host innate immunity response. Here, we report that the robust production of type I and III interferons (IFNs), IFN-stimulated genes, and proinflammatory factors can be induced by influenza B virus rather than influenza A virus infection in alveolar epithelial (A549) cells during early infection. This response is mainly dependent on the retinoic acid-inducible gene I (RIG-I)-mediated signaling pathway. Infection by influenza B virus promotes intense Lys63-linked ubiquitination of RIG-I, resulting in cytokine eruption. It is known that the influenza A virus NS1 protein (NS1-A) interacts with RIG-I and TRIM25 to suppress the activation of RIG-I-mediated signaling. However, the present results indicate that the influenza B virus NS1 protein (NS1-B) is unable to interact with RIG-I but engages in the formation of a RIG-I/TRIM25/NS1-B ternary complex. Furthermore, we demonstrate that the N-terminal RNA-binding domain (RBD) of NS1-B is responsible for interaction with TRIM25 and that this interaction blocks the inhibitory effect of the NS1-B C-terminal effector domain (TED) on RIG-I ubiquitination. Our findings reveal a novel mechanism for the host cytokine response to influenza B virus infection through regulatory interplay between host and viral proteins. IMPORTANCE: Influenza B virus generally causes local mild epidemics but is occasionally lethal to individuals. Existing studies describe the broad characteristics of influenza B virus epidemiology and pathology. However, to develop better prevention and treatments for the disease, determining the concrete molecular mechanisms of pathogenesis becomes pivotal to understand how the host reacts to the challenge of influenza B virus. Thus, we aimed to characterize the host innate immune response to influenza B virus infection. Here, we show that vigorous Lys63-linked ubiquitination of RIG-I and cytokine eruption dependent on RIG-I-mediated signal transduction are induced by virus infection. Additionally, TRIM25 positively regulates RIG-I-mediated signaling by ablating the inhibitory function of NS1-B on RIG-I ubiquitination.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27122586      PMCID: PMC4936144          DOI: 10.1128/JVI.00549-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Type 1 interferons and the virus-host relationship: a lesson in détente .

Authors:  Adolfo García-Sastre; Christine A Biron
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

2.  Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance.

Authors:  Lars Ketscher; Ronny Hannß; David J Morales; Anja Basters; Susana Guerra; Tobias Goldmann; Annika Hausmann; Marco Prinz; Ronald Naumann; Andrew Pekosz; Olaf Utermöhlen; Deborah J Lenschow; Klaus-Peter Knobeloch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

3.  Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon.

Authors:  Bianca Dauber; Jana Schneider; Thorsten Wolff
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

4.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

5.  Influenza virus-host interactome screen as a platform for antiviral drug development.

Authors:  Tokiko Watanabe; Eiryo Kawakami; Jason E Shoemaker; Tiago J S Lopes; Yukiko Matsuoka; Yuriko Tomita; Hiroko Kozuka-Hata; Takeo Gorai; Tomoko Kuwahara; Eiji Takeda; Atsushi Nagata; Ryo Takano; Maki Kiso; Makoto Yamashita; Yuko Sakai-Tagawa; Hiroaki Katsura; Naoki Nonaka; Hiroko Fujii; Ken Fujii; Yukihiko Sugita; Takeshi Noda; Hideo Goto; Satoshi Fukuyama; Shinji Watanabe; Gabriele Neumann; Masaaki Oyama; Hiroaki Kitano; Yoshihiro Kawaoka
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

6.  Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins.

Authors:  Haripriya Sridharan; Chen Zhao; Robert M Krug
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

7.  Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication.

Authors:  Xiaoling Liu; Lei Sun; Maorong Yu; Zengfu Wang; Chongfeng Xu; Qinghua Xue; Ke Zhang; Xin Ye; Yoshihiro Kitamura; Wenjun Liu
Journal:  Cell Microbiol       Date:  2009-01-15       Impact factor: 3.715

8.  The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction.

Authors:  Bianca Dauber; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Incoming influenza A virus evades early host recognition, while influenza B virus induces interferon expression directly upon entry.

Authors:  Pamela Österlund; Mari Strengell; L Peter Sarin; Minna M Poranen; Riku Fagerlund; Krister Melén; Ilkka Julkunen
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

10.  Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR.

Authors:  Bianca Dauber; Luis Martínez-Sobrido; Jana Schneider; Rong Hai; Zoe Waibler; Ulrich Kalinke; Adolfo García-Sastre; Thorsten Wolff
Journal:  PLoS Pathog       Date:  2009-06-12       Impact factor: 6.823

View more
  16 in total

Review 1.  Cytoplasm and Beyond: Dynamic Innate Immune Sensing of Influenza A Virus by RIG-I.

Authors:  GuanQun Liu; Yan Zhou
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

2.  "Toll-free" pathways for production of type I interferons.

Authors:  Ling Wang; Shunbin Ning
Journal:  AIMS Allergy Immunol       Date:  2017-11-06

3.  The innate immunity of guinea pigs against highly pathogenic avian influenza virus infection.

Authors:  Kun Zhang; Wei Wei Xu; Zhaowei Zhang; Jing Liu; Jing Li; Lijuan Sun; Weiyang Sun; Peirong Jiao; Xiaoyu Sang; Zhiguang Ren; Zhijun Yu; Yuanguo Li; Na Feng; Tiecheng Wang; Hualei Wang; Songtao Yang; Yongkun Zhao; Xuemei Zhang; Peter R Wilker; WenJun Liu; Ming Liao; Hualan Chen; Yuwei Gao; Xianzhu Xia
Journal:  Oncotarget       Date:  2017-05-02

4.  Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses.

Authors:  Wei Liu; Jing Li; Weinan Zheng; Yingli Shang; Zhendong Zhao; Shanshan Wang; Yuhai Bi; Shuang Zhang; Chongfeng Xu; Ziyuan Duan; Lianfeng Zhang; Yue L Wang; Zhengfan Jiang; Wenjun Liu; Lei Sun
Journal:  Elife       Date:  2017-06-08       Impact factor: 8.140

Review 5.  Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity.

Authors:  Yiliu Liu; David Olagnier; Rongtuan Lin
Journal:  Front Immunol       Date:  2017-01-03       Impact factor: 7.561

6.  Influence of Novel Highly Pathogenic Avian Influenza A (H5N1) Virus Infection on Migrating Whooper Swans Fecal Microbiota.

Authors:  Na Zhao; Supen Wang; Hongyi Li; Shelan Liu; Meng Li; Jing Luo; Wen Su; Hongxuan He
Journal:  Front Cell Infect Microbiol       Date:  2018-02-22       Impact factor: 5.293

Review 7.  The TRIMendous Role of TRIMs in Virus-Host Interactions.

Authors:  Sarah van Tol; Adam Hage; Maria Isabel Giraldo; Preeti Bharaj; Ricardo Rajsbaum
Journal:  Vaccines (Basel)       Date:  2017-08-22

8.  Human interactome of the influenza B virus NS1 protein.

Authors:  Corinna Patzina; Catherine H Botting; Adolfo García-Sastre; Richard E Randall; Benjamin G Hale
Journal:  J Gen Virol       Date:  2017-09-04       Impact factor: 3.891

9.  A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus.

Authors:  Can Chen; Wenhui Fan; Jing Li; Weinan Zheng; Shuang Zhang; Limin Yang; Di Liu; Wenjun Liu; Lei Sun
Journal:  Front Cell Infect Microbiol       Date:  2018-05-01       Impact factor: 5.293

Review 10.  IFN-λ: A new spotlight in innate immunity against influenza virus infection.

Authors:  Yeping Sun; Jingwen Jiang; Po Tien; Wenjun Liu; Jing Li
Journal:  Protein Cell       Date:  2018-10       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.